Dedicated to Finding New Medicines Through Targeting the Ubiquitin Proteasome System

News and Events


Dr. Tauseef Butt, President and CEO, recently spoke at CHI’s 13th  Annual Drug Discovery Chemistry 2018 Conference  on inhibitors of ubiquitin protease 7 (USP7), and their role in immune oncology.

Learn More >


Upcoming Meetings

Dr. Suresh Kumar, Senior Director and Head of Drug Discovery, will speak at Cambridge Healthtech Institute’s Annual Discovery on Target: September 25-28, 2018. Boston, MAHe will speak on “Small Molecule Immune Oncology Therapies from Ubiquitin Proteasome System”.

Learn More >


Business Development

Progenra is seeking industry partnerships for licensing opportunities surrounding the company’s small molecule portfolio Drug Discovery Platform


Learn More >